Medtronic Secures China Market Approval for Pulsed Electric Field Atrial Fibrillation Treatment Devices
Medtronic (NYSE: MDT), the US-Irish medical technology giant, has announced that it has received approvals...
Medtronic (NYSE: MDT), the US-Irish medical technology giant, has announced that it has received approvals...
China Isotope & Radiation Corporation’s (CIRC) subsidiary, HTA Co., Ltd. (HKG: 1763), has announced that...
Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196) has announced that the National...
Amoy Diagnostics Co., Ltd (AmoyDx, SHE: 300685), a biopharmaceutical company based in China, has announced...
Fujirebio Inc., a leading diagnostic company based in Japan, has received approval from China’s National...
Genesis MedTech, a leading medical device company headquartered in Singapore, has secured marketing approvals from...
True Health (Guangdong Hengqin) Medical Technology Co., Ltd has received marketing approval from China’s National...
Sansure Biotech Inc., (SHA: 688289), a leading molecular diagnostics company based in China, has announced...
Jafron Biomedical Co., Ltd, a prominent player in the blood purification sector based in China,...
BEIJING—Beijing Balance Medical Technology Co., Ltd (SHA: 688198) has received market approval from the National...
HONG KONG—Sino Medical Sciences Technology Inc., (SHA: 688108), a leading medical device company based in...
NEW YORK—Boston Scientific Corporation (NYSE: BSX), a leading innovator in medical solutions, has secured a...
Jiangxi Jemincare Group, based in China, has received marketing approval from the National Medical Products...
JW Therapeutics, a biopharmaceutical company based in China and listed on the Hong Kong Stock...
Legend Biotech Corporation (NASDAQ: LEGN) has secured a significant milestone with the announcement of marketing...
Jiangsu Hengrui Pharmaceuticals Co., Ltd, a Chinese pharmaceutical company listed on the Shanghai Stock Exchange...
Chongqing Genrix Biopharmaceutical Co., Ltd, a Chinese biopharmaceutical company, has received marketing approval from China’s...
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) has secured its first global market approval for Ordspono (odronextamab)...
Shanghai MicroPort Endovascular MedTech Co., Ltd, a Chinese endovascular device manufacturer listed on the Shanghai...
Shanghai Henlius Biotech Inc., a leading biopharmaceutical company based in China and listed on the...